What are Generex' priorities? What are we looking
Post# of 36536
Dividends-GNBT and NGIO....happening, slowly, but happening
NGIO Spin-off/Listing on NASDAQ..have to pay the dividend, populate the board, submit an s1....go public when approved by finra....that's an easy one (pristine is how Joe described it)
AE 37 Trial Results....cancer research takes time, a looooong time...have to wait on this one.....
S-1 $40M....its a done deal...have to pay the dividend, to know how many shares outstanding, to price the s1...collect money at the ATM...
GNBT Uplisting....i hope they have put this on a back burner somewhere...this will not farewell for us....so please don't ask for it....
Excellagen sales and revenues....would 450,000 in Nov. sales impress you?....well we got that, b4 the indians started their orders....
Altucell Acquisition/By Extension Rebirth of Diabetes Franchise/Oralyn
dividend has to be paid, for finra to know shares outstanding, for finra to price s1, for generex to pay 2.5 million in cash to altucell for things to go....
MSO/Unsure of Its Current Stage of Completion....just waiting on funds from s1 to fire this baby back on....doctors are waiting in line...(its their investment)
Honestly, I have lost track of where we are in relation to other initiatives. Feel free to add them or insert your own priorities.
No one can say Generex is a one-trick biotech pony, but can all this still be accomplished? So much promise and so much concern. It definitely is not boring.
i'd rather be in this non-boring investment any day....much better than the 200 and 300 dollars am making daily on buying and selling stocks same hour....